Eliglustat
CAS 491833-29-5 3 FDA-DMF suppliersSmall Molecule
Overview
Eliglustat is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2110588).
API suppliers (3)
Suppliers of Eliglustat backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Taiji Biopharmaceuticals Pvt. Ltd.India1 active DMF
- TIANISH LABORATORIES PRIVATE LTDIndia1 active DMF
- Apotex Inc.Canada1 active DMF
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Eliglustat expires 13 Dec 2038. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[(1R,2R)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)-1-hydroxy-3-pyrrolidin-1-ylpropan-2-yl]octanamide
- Canonical SMILES
- CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@@H](C2=CC3=C(C=C2)OCCO3)O
- InChIKey
- FJZZPCZKBUKGGU-AUSIDOKSSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.